Crossmark

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2018.30

Published Online: 2018-02-27

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Widschwendter, Martin

Jones, Allison

Evans, Iona

Reisel, Daniel

Dillner, Joakim

Sundström, Karin

Steyerberg, Ewout W.

Vergouwe, Yvonne

Wegwarth, Odette

Rebitschek, Felix G.

Siebert, Uwe

Sroczynski, Gaby

de Beaufort, Inez D.

Bolt, Ineke

Cibula, David

Zikan, Michal

Bjørge, Line

Colombo, Nicoletta

Harbeck, Nadia

Dudbridge, Frank

Tasse, Anne-Marie

Knoppers, Bartha M.

Joly, Yann

Teschendorff, Andrew E.

Pashayan, Nora
License Information

Text and Data Mining valid from 2018-02-27
More Information

Article History

First Online: 27 February 2018

Competing interests

: The authors declare no competing financial interests.